Latest Releases
U.S. Senator Tina Smith’s Statement on the Department of Justice’s Report on Policing Practices in Minneapolis
WASHINGTON, D.C. [06/16/23] — Today, U.S. Senator Tina Smith (D-Minn.) issued the following statement on the Department of Justice’s report detailing the results of their patterns and practices investigation of the Minneapolis Police Department: “I commend the Department of Justice for its thorough investigation into the patterns and practices of the Minneapolis Police Department. Following the tragic murder of George Floyd, and the violence and harm done to too many people at the hands of the MPD, I called on the Department of Justice to conduct this investigation. The findings released today enumerate in vivid and heartbreaking detail what members of this community have known for a long time, that the MPD has engaged in longstanding practices that deny people their rights under the Constitution and federal law, and has brought lasting and real harm to people. Nonetheless, it is shocking to see spelled out the discriminatory, violent and unaccountable behavior of MPD, especially toward Black and Native American people, and those living with behavioral disabilities. “Every Minnesotan deserves to be safe and protected by law enforcement in their community. Minneapolis has taken some initial steps in advancing reforms, and this investigation provides a template for the work ahead to remake MPD policies, supervision, training, and officer wellness programs so we have true accountability. I’m grateful for the city leaders, faith leaders, public safety and mental health providers, and all the community members who provided their experiences for this report. “I am also deeply aware of the challenges facing MPD officers, and
Senators Tina Smith, Jerry Moran Push to Lower Cost of Cancer Treatments
WASHINGTON, D.C. [6.15.23] – Today, U.S. Senators Tina Smith (D-MN) and Jerry Moran (R-KS) introduced bipartisan legislation to ensure cancer patients who receive oral medications are not hit with thousands of dollars in unaffordable out-of-pocket costs that health plans routinely cover for patients receiving traditional IV chemotherapy treatments. Their Cancer Drug Parity Act responds to the recent improvements in oral medications for cancer by preventing insurers from charging cancer patients higher copayments for those medications than for chemotherapy medicine delivered intravenously. An estimated 2 million Americans will be are diagnosed with cancer this year. A study on patients prescribed oral cancer medications found that one in eight patients faced copayments of $2,000 or more for their first prescription. “Advancements in oral cancer medications have made life better for cancer patients across the country,” said Sen. Smith. “Oral medications are less intrusive than traditional IV treatments, can be taken at home, and have turned cancer into a manageable chronic disease for many. But while IV treatments are covered by a health plan’s medical benefits – with moderate to minimal copays – oral medications often have high, unaffordable copays. It can add up to thousands of dollars in costs for patients each year and can cause many to delay or forego necessary care to treat their cancer. Our bill brings parity to these two kinds of treatments and lowers costs for those taking oral cancer drugs.” “As the number of orally administered cancer drugs increases each year, patients ought to be able to
Bipartisan, bicameral bill from Sens. Coons, Risch, Smith, Gardner & Reps Luján, Fleischmann, Hultgren, Lipinski supports small business innovation
WASHINGTON – U.S. Senators Chris Coons (D-DE), James Risch (R-ID), Tina Smith (D-MN), and Cory Gardner (R-CO) and U.S. Representatives Ben Ray Luján (D-NM), Chuck Fleischmann (R-TN), Randy Hultgren (R-IL), and Daniel Lipinski (D-IL) today introduced the Promoting Small Business Innovation through Partnerships with National Labs Act, which allows small businesses to gain access to premier facilities at the national labs, spurring innovation and stimulating the culture of private-public collaboration. Small businesses are the lifeblood of the American economy. However, the cost of investing in necessary but expensive capital equipment often prohibits small businesses from pursuing truly innovative ideas and developing
Sen. Tina Smith Says Minnesotans Deserve to Know How Drug Companies Are Using Billions in Tax Breaks
WASHINGTON, D.C. [05/17/18]—Today, U.S. Senator Tina Smith is introducing legislation that would require pharmaceutical companies to share with Minnesotans and people across the country how they’re using the billions of dollars in tax breaks they received as a result of the Republican tax bill. The GOP tax law provided pharmaceutical companies with large windfalls that could have been used to bring down costs for consumers. But earlier this year, news reports showed that some top pharmaceutical companies used a large chunk of their tax cuts to benefit investors and drive up stocks. Sen. Smith’s bill—the Disclosing Pharmaceutical Company Windfall Profits Act—would make
Sen. Tina Smith Pressing for Senate Hearing on Novartis Payments to Trump Lawyer Michael Cohen
WASHINGTON, D.C. [05/17/18]—U.S. Senator Tina Smith (D-Minn.) is calling for a full investigation of the payments Novartis made to President Trump’s personal attorney Michael Cohen and is asking the leaders of the Senate Health Committee to hold a hearing with the CEO of Novartis as the key witness. Sen. Smith expresses concern that the payments may have played a role in shaping the Trump Administration’s positions on issues affecting Novartis and other drug makers, including importation of cheaper drugs from abroad. You can read a copy of the letter Sen. Smith sent by clicking here. “Discovery of these payments comes at
Sen. Tina Smith Condemns Secretary DeVos Dismantling Protections Against Predatory Practices by For-Profit Colleges
WASHINGTON, D.C. [05/25/18]—U.S Senator Tina Smith (D-Minn.) joined 28 of her colleagues in condemning Education Secretary Betsy DeVos’ dismantling of a crucial office designed to protect students against predatory practices by for-profit colleges. Tasked with investigating schools that cheat, mislead, or defraud students, recent media reports have indicated staff and resources of the Department of Education’s Student Aid Enforcement Unit are being systematically reduced by Secretary DeVos. This is occurring while Secretary DeVos has simultaneously hired former executives from for-profit colleges that were previously under investigation by the same unit. “It is critically important that the Department fulfill its mission to protect students in higher
English